Results 121 to 130 of about 86,799 (302)
Movement Disorders Clinical Practice, EarlyView.Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz +2 more
wiley +1 more source
The segmentation procedure for the substantia nigra and nigrostriatal structures.
, 2012 An illustration of reformatting position used for the segmentation of the substantia nigra (1A) and the segmentation example of the nigrostriatal structures (1B and 1C).
Xuemei Huang (170562) +6 more
core +1 more source
EFFECT OF THE NUCLEUS CAUDATUS AND THE DOPAMINERGIC NEURON ON ACUPUNCTURE ANALGESIA
针刺研究, 1980 The present paper is divided into two parts.The nucleus caudatus has been described briefly in the first part.(1) The nervous circuity ofnucleus eaudatus:The pars compacta of substantia nigra contains the cell body of one of the maindopamine(DA) fiber ...
Sun Deyu
doaj
Homogenous Cell Transplantation Trials in Parkinson's Disease: A Systematic Review and Meta‐Analysis
Movement Disorders Clinical Practice, EarlyView.Abstract Background The transplantation of homogenous cells has emerged as an investigational strategy for Parkinson's disease (PD), offering an alternative to symptomatic treatment. Objective We performed a systematic review and meta‐analysis to assess its clinical efficacy and safety.
Nolan Reinisch +4 more
wiley +1 more source
Neuromelanin in substantia nigra quantification from neuromelanin-sensitive MRI images
, 2019 Neuromelanin je černý pigment nacházející se v mozku v substantia nigra pars compacta a locus coeruleus. Jeho ztráta má přímou souvislost se ztrátou nervových buněk v této části mozku.
Martin Lang
core
Differential Metabolism of Dynorphins in Substantia Nigra, Striatum, and Hippocampus
, 1997 To map the proteolytic enzymes metabolizing dynorphins in brain structures, size-exclusion chromatography linked to electrospray ionization mass spectrometry was used. Enzymes extracted from rat hippocampus, striatum, and substantia nigra were tested for
Koichi Tan-No +20 more
core +1 more source
Substantia nigra control of basal ganglia nuclei
, 2009 . The substantia nigra, located in the ventral mesencephalon, is one of the five nuclei that constitute the basal ganglia circuit, which controls voluntary movements.
CUCCHIARONI ML +2 more
core
Reply: To Exercise at High Intensity Heart Rate or Not to Exercise at High Intensity Heart Rate?
Movement Disorders Clinical Practice, EarlyView.
Lennard I. Boon +2 more
wiley +1 more source
Placebo Effect in Levodopa‐Induced Dyskinesia: A Systematic Review and Meta‐Analysis
Movement Disorders Clinical Practice, EarlyView.Abstract Background Levodopa‐induced dyskinesia (LID) is a complication of Parkinson's disease (PD) treatment. While the placebo effect is a known component in PD clinical trials, its specific magnitude in the context of LID is not well characterized.
Luiz Vinicius Silva Correa +5 more
wiley +1 more source